Express Scripts Holding (ESRX) Expected to Earn Q1 2018 Earnings of $1.93 Per Share
Express Scripts Holding (NASDAQ:ESRX) – Research analysts at William Blair increased their Q1 2018 earnings estimates for shares of Express Scripts in a research note issued to investors on Tuesday. William Blair analyst J. Kreger now expects that the company will earn $1.93 per share for the quarter, up from their previous forecast of $1.61. William Blair also issued estimates for Express Scripts’ Q2 2018 earnings at $2.37 EPS, Q3 2018 earnings at $2.44 EPS, Q4 2018 earnings at $2.63 EPS, FY2018 earnings at $9.37 EPS, Q1 2019 earnings at $2.17 EPS, Q2 2019 earnings at $2.49 EPS, Q3 2019 earnings at $2.68 EPS, Q4 2019 earnings at $2.95 EPS, FY2019 earnings at $10.28 EPS, FY2020 earnings at $9.10 EPS and FY2021 earnings at $8.10 EPS.
A number of other equities analysts also recently issued reports on ESRX. Royal Bank of Canada started coverage on shares of Express Scripts in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 price target for the company. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. UBS Group cut shares of Express Scripts from a “market perform” rating to an “underperform” rating in a research note on Monday, October 9th. Raymond James Financial reissued an “underperform” rating on shares of Express Scripts in a research note on Monday, October 9th. Finally, Zacks Investment Research raised shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price objective on the stock in a research note on Monday, October 16th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $77.09.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.90. The business had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business’s revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the firm posted $1.74 EPS.
Several institutional investors have recently added to or reduced their stakes in ESRX. Hexavest Inc. boosted its position in shares of Express Scripts by 1.1% in the fourth quarter. Hexavest Inc. now owns 500,235 shares of the company’s stock worth $37,338,000 after acquiring an additional 5,366 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of Express Scripts by 8.1% in the fourth quarter. Nisa Investment Advisors LLC now owns 233,538 shares of the company’s stock worth $17,431,000 after acquiring an additional 17,441 shares during the last quarter. Hikari Power Ltd boosted its position in shares of Express Scripts by 36.6% in the fourth quarter. Hikari Power Ltd now owns 134,600 shares of the company’s stock worth $10,047,000 after acquiring an additional 36,040 shares during the last quarter. Sawyer & Company Inc acquired a new stake in shares of Express Scripts in the fourth quarter worth approximately $559,000. Finally, Investors Asset Management of Georgia Inc. GA ADV acquired a new stake in shares of Express Scripts in the fourth quarter worth approximately $233,000. 88.28% of the stock is currently owned by institutional investors.
In other news, CEO Timothy C. Wentworth purchased 8,000 shares of the firm’s stock in a transaction on Tuesday, October 31st. The shares were bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the purchase, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Christine Houston sold 10,104 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the sale, the vice president now directly owns 87,400 shares in the company, valued at $6,124,992. The disclosure for this sale can be found here. Insiders have sold a total of 17,644 shares of company stock worth $1,289,609 over the last ninety days. 0.68% of the stock is owned by corporate insiders.
Express Scripts announced that its board has initiated a stock buyback program on Monday, December 18th that authorizes the company to repurchase 45,000,000 outstanding shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are usually a sign that the company’s board believes its shares are undervalued.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.